Corrigendum: Improving anti-tumor efficacy of low-dose Vincristine in rhabdomyosarcoma
FOXM1 inhibitor
animal models
combination therapy
nanoparticles
rhabdomyosarcoma
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
02
2023
accepted:
30
03
2023
medline:
1
5
2023
pubmed:
1
5
2023
entrez:
1
5
2023
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fonc.2023.1112859.].
Identifiants
pubmed: 37124500
doi: 10.3389/fonc.2023.1163510
pmc: PMC10135300
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
1163510Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2023 Donovan, Deng, Bian, Shukla, Gomez-Arroyo, Shi, Kalinichenko and Kalin.